Breast Care

Case Report · Kasuistik

Free Access

Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation

Savelli G.a · Zaniboni A.b · Bertagna F.c · Bosio G.c · Nisa L.c · Rodella C.c · Biasiotto G.c · Bettinsoli G.c · Migliorati E.c · Peli A.c · Falchi R.a · Giuffrida F.a · Giubbini R.c

Author affiliations

aNuclear Medicine Unit, ‘Carlo Poma’ Civic Hospital, Mantua, bOncology Division, ‘IC Fondazione Poliambulanza’, cNuclear Medicine Unit, ‘Spedali Civili’ Hospital, Brescia, Italy

Corresponding Author

Giordano Savelli, MD

Nuclear Medicine Unit

Mantua Civic Hospital ‘Carlo Poma’

Strada Iago Paiolo, 10

46100, Mantua, Italy

giordano.savelli@aopoma.it

Related Articles for ""

Breast Care 2012;7:408–410

Abstract

Background: Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies. Case Report: A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy. Conclusion: PRRT may be useful in metastatic BC patients.




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Case Report · Kasuistik

Published online: October 22, 2012
Issue release date: October 2012

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0

ISSN: 1661-3791 (Print)
eISSN: 1661-3805 (Online)

For additional information: https://www.karger.com/BRC


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP